Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 USD | -12.62% | +7.27% | -69.01% |
May. 02 | Nuwellis, Inc. Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology | CI |
Apr. 29 | Maxim Downgrades Nuwellis to Hold | MT |
Evolution of the average Target Price on Nuwellis, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Nuwellis, Inc.
Maxim | |
Ladenburg Thalmann |
EPS Revisions
- Stock Market
- Equities
- NUWE Stock
- Consensus Nuwellis, Inc.